Showing 641 - 660 results of 9,864 for search '"drug"', query time: 0.09s Refine Results
  1. 641

    A multistage drug delivery approach for colorectal primary tumors and lymph node metastases by Yihang Yuan, Quanjun Lin, Hai-Yi Feng, Yunpeng Zhang, Xing Lai, Mao-Hua Zhu, Jue Wang, Jiangpei Shi, Yanhu Huang, Lele Zhang, Qin Lu, Zeli Yuan, Jonathan F. Lovell, Hong-Zhuan Chen, Peng Sun, Chao Fang

    Published 2025-02-01
    “…Taken together, this study demonstrates a deliberate treatment approach for management of both primary tumors and metastatic LNs through multistage drug delivery.…”
    Get full text
    Article
  2. 642

    Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models by Chrystal Paulos, Gregory B Lesinski, Zachary S Buchwald, Nabil F Saba, Vikash Kansal, Andre J Burnham, Brendan L C Kinney, Nicole C Schmitt

    Published 2023-01-01
    “…Background Anti-PD-1 immune checkpoint blockade is approved for first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), but few patients respond. Statin drugs (HMG-CoA reductase inhibitors) are associated with superior survival in several cancer types, including HNSCC. …”
    Get full text
    Article
  3. 643
  4. 644

    Localized Drug Delivery in Different Gastrointestinal Cancers: Navigating Challenges and Advancing Nanotechnological Solutions by Hasan AM, Cavalu S, Kira AY, Hamad RS, Abdel-Reheim MA, Elmorsy EA, El-kott AF, Morsy K, AlSheri AS, Negm S, Saber S

    Published 2025-01-01
    “…To overcome these obstacles, nano-drug delivery systems (NDDs) have been designed and proved their potential by exploiting these challenges in favor of offering a specific delivery to the desired target. …”
    Get full text
    Article
  5. 645
  6. 646

    Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance by Peng Zhao, Shuangshuang Yin, Yuling Qiu, Changgang Sun, Haiyang Yu

    Published 2025-01-01
    “…Abstract Drug resistance is a common challenge in clinical tumor treatment. …”
    Get full text
    Article
  7. 647

    Adaptation of Color Reactions for Spectrophotometric Determination of Pitavastatin Calcium in Bulk Drugs and in Pharmaceutical Formulations by Marothu Vamsi Krishna, Dannana Gowri Sankar

    Published 2007-01-01
    “…Three simple, sensitive and cost effective Spectrophotometric methods are described for the determination of pitavastatin calcium (PST) in bulk drugs and in pharmaceutical formulations. These methods are based on the oxidation of PST by ferric chloride in presence of o-phenanthroline (Method A) or 2, 2’ bipyridyl (Method B) or potassium ferricyanide (Method C). …”
    Get full text
    Article
  8. 648

    A Lethal Complication after Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma by Adriana Toro, Gaetano Bertino, Maria Concetta Arcerito, Maurizio Mannnino, Annalisa Ardiri, Domenico Patane’, Isidoro Di Carlo

    Published 2015-01-01
    “…TACE may also be performed with drug-eluting beads, but serious complications of this procedure have been reported. …”
    Get full text
    Article
  9. 649

    Nonlinearities in Drug Release Process from Polymeric Microparticles: Long-Time-Scale Behaviour by Elena Simona Bacaita, Costica Bejinariu, Borsos Zoltan, Catalina Peptu, Gabriela Andrei, Marcel Popa, Daniela Magop, Maricel Agop

    Published 2012-01-01
    “…A theoretical model of the drug release process from polymeric microparticles (a particular type of polymer matrix), through dispersive fractal approximation of motion, is built. …”
    Get full text
    Article
  10. 650
  11. 651
  12. 652

    Pharmacogenetic markers of colorectal cancer treatment. New approaches for cytostatic drugs efficacy estimation by N. B. Zakharzhevskaya, N. A. Kulemin, Ye. A. Babikova, Ye. B. Khomyakova, E. V. Generozov

    Published 2015-12-01
    “…If efficacy and necessity of pharmacogenetic investigation for such drugs of targeted therapy, as cetuximab, is already proven for the present time, it is still underestimated for the widely applied drugs of general cytostatic action. …”
    Get full text
    Article
  13. 653

    Mathematical Modeling and Optimal Control Strategy for a Discrete Time Drug Consumption Model by Abderrahim Labzai, Abdelfatah Kouidere, Bouchaib Khajji, Omar Balatif, Mostafa Rachik

    Published 2020-01-01
    “…The aim of this paper is to study and investigate the optimal control strategy of a discrete mathematical model of drug consumption. The population that we are going to study is divided into six compartments: potential drug users, light drug users, heavy drug users, heavy drug users-dealers and providers, temporary quitters of drug consumption, and permanent quitters of drug consumption. …”
    Get full text
    Article
  14. 654
  15. 655
  16. 656

    Automated Subfield Volumetric Analysis of Hippocampus in Patients with Drug-Naïve Nondementia Parkinson’s Disease by Jin-Woo Park, Chan-Nyoung Lee, Youngbo Sim, Hyung-Kyu Ham, Woo-Suk Tae, Byung-Jo Kim

    Published 2019-01-01
    “…A total of 32 subjects were enrolled in this study (sixteen patients with drug naive nondementia PD and sixteen healthy controls). …”
    Get full text
    Article
  17. 657
  18. 658
  19. 659
  20. 660

    Analyses of urogenital Mycoplasma hominis and Ureaplasma urealyticum infections and drug sensitivity in 296 patients by CHEN Junwei, HUANG Sheng, QIU Wei, XIAO Yupeng

    Published 2025-01-01
    “…[Objective] To analyze urogenital Mycoplasma hominis (Mh) and Ureaplasma urealyticum (Uu) infections and drug sensitivity, providing a rationale for choosing antibiotics in clinical practice. …”
    Get full text
    Article